Sotrovimab
Definition: Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2, known as SARS-CoV-2. It was developed by GlaxoSmithKline and Vir Biotechnology, Inc. Sotrovimab is designed to attach to the spike protein of SARS-CoV-2. source: Wikipedia
- ID
- 1162689008
- ID date
- 17 Jun 2022
- Previous ID
- 40228711000001108
- Name
- Sotrovimab